UBS Maintains a 'Neutral' on Novellus (NVLS); Strong Deposition Business is Rewarded

December 15, 2011 11:23 AM EST
Get Alerts NVLS Hot Sheet
Price: $2.40 --0%

Rating Summary:
    1 Buy, 4 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on Novellus (NASDAQ: NVLS) price target raised from $34 to $44.

UBS analyst says, "We believe Lam Research’s (Nasdaq: LRCX) $3.3B all stock bid for Novellus today reflects Novellus’ solid technology development in deposition and dry strip equipment. We note this acquisition will be complimentary for Lam, as it currently serves the etch and clean equipment markets."

"With key inflection points, such as the transition to 450mm wafers, on the horizon, we view the acquisition positively for Novellus as it likely benefits from Lam’s complimentary customer relationships and products and deep technical knowledge. By providing a single face to customers, Novellus will likely benefit from additional exposure to customers such as Toshiba, which we estimate has historically accounted for 11% of Lam’s total sales."

For an analyst ratings summary and ratings history on Novellus click here. For more ratings news on Novellus click here.

Shares of Novellus closed at $34.70 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

UBS